Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study).

BMC Infect Dis · 2019 · PMC6396540 · PMID 30819101

Europe PMC DOI

hedged sentence

0.4620

closest p · 9.2× alpha

0.4620

boldest claim

The sentences

did not reach statistical significancep = 0.462not close (p > 0.1)

A higher increase of LDL-cholesterol was observed with ritonavir (+ 20 mg/dL) than with cobicistat (+ 10 mg/dL), but the difference did not reach statistical significance ( p = 0.462).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.